Quantcast

RDEA

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to acquire the company.  With another small-cap to mid-cap biotech and ...
Read Full Story »

Top Analyst Upgrades & Downgrades (AEG, AA, AGU, RDEA, CTL, CERN, COP, CNX, DMND, FCX, GOOG, IBN, JPM, NEM, BTU, SWC, STM, RIG, VICL)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning. AEGON N.V. (NYSE: AEG) maintained "Buy" but removed from Conviction ...
Read Full Story »

BioHealth Business Daily (RDEA, AVNR, CELG, DNDN, ENCO, OPXA, PURE, SVA)

Today’s wrap of the BioHealth Business Daily includes many less-covered stocks moving on news.  We are seeing significant and unusual price changes in shares of Ardea Biosciences, Inc. (NASDAQ: RDEA), ...
Read Full Story »

Opening Bell Day Trader Alerts (KBH, PHM, LIHR, MPEL, AVNR, AMSC, RDEA, CA, CPBY, MEE, CIGX, TIVO)

Credit Suisse hit the homebuilders... KB Home (NYSE: KBH) is down 2.3% at $16.60 on fairly thin trading volume after it was lowered to Neutral from Outperform.  Pulte Homes (NYSE: ...
Read Full Story »